Market Overview
| Study Period | 2020 - 2031 |
|---|---|
| Forecast Data Period | 2026 - 2031 |
| Base Year Market Size (2025) | USD 1.03 Billion |
| Market Size (2026) | USD 1.23 Billion |
| Market Size (2031) | USD 2.92 Billion |
| Growth Rate (2026 - 2031) | 18.95% CAGR |
| Market Concentration | Medium |
Major Players *Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. | |
Asia-Pacific Remote Patient Monitoring System Market Analysis by Mordor Intelligence
The Asia-Pacific Remote Patient Monitoring System Market size was valued at USD 1.03 billion in 2025 and estimated to grow from USD 1.23 billion in 2026 to reach USD 2.92 billion by 2031, at a CAGR of 18.95% during the forecast period (2026-2031).
The COVID-19 pandemic placed enormous pressure on hospitals and healthcare systems that were understaffed and overworked. Remote patient monitoring technology helped patients remain safe within their homes while reducing stress on hospitals, emergency rooms, and front-line healthcare workers during the pandemic, thereby positively impacting the market. in February 2022, Sino Group supplied residential care homes handling mild COVID-19 cases with 500 units of a remote monitoring system by Belun Technology Company through its charitable arm, Ng Teng Fong Charitable Foundation. To deliver Belun's remoVital remote monitoring system, the group collaborated with the Social Welfare Department and the Hong Kong Council of Social Service (HKCSS). Companies were expected to invest in RPM devices to adapt to their ready-to-work protocols during the pandemic as most COVID-19 patients were asymptomatic. COVID has boosted the adoption of remote patient monitoring system and although currently COVID-19 cases have been subsidized, the increasing burden of other chronic diseases are expected to lead to stable growth of the market in the next 3-4 years.
Certain factors that are propelling the growth of the market are the rising incidences of chronic diseases due to lifestyle changes, the increase in the aging population, the need to contain healthcare expenditure, the demand for home-based monitoring devices, and ease of use and portability of devices to promote the growth. For instance, according to the United Nations Population Fund, 2022 statistics, in China, 70% of the living population is aged 15-64 in 2022. In addition, as per the same source, 13% of the population is aged 65 years and above in 2022. Thus, the rising geriatric populations are more prone to develop chronic diseases which require proper monitoring and diagnosis which is expected to increase the adoption of remote patient monitoring to regularly monitor their condition and status, thereby propelling the growth of the studied market. Additionally, China carries a heavy burden of chronic diseases, such as cancer, obesity, diabetes, and others, which are expected to drive the growth of the studied market. For instance, as per the 2022 update from the International Diabetic Federation (IDF), approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Such an increase in chronic diseases is expected to drive the demand for remote patient monitoring systems, thereby driving the growth of the market.
Additionally, the increasing product approvals in this region are also expected to contribute to the market's growth. For instance, in March 2021 Dozee launched a contactless remote patient monitoring solution for solutions in India. The Dosee Pro solution featured an AI-powered triaging system that enables remote monitoring of patients outside of the Intensive Care Unit (ICU).
Thus the factors such as the rising incidences of chronic diseases due to lifestyle changes, the increase in the aging population, the need to contain healthcare expenditure, the demand for home-based monitoring devices, and ease of use and portability of devices to promote the growth are expected to drive the growth of the market over the forecast period. However, resistance from healthcare industry professionals and stringent regulatory frameworks is expected to restrain the growth of the market.
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of 2026.
Asia-Pacific Remote Patient Monitoring System Market Trends and Insights
Cancer Treatment are Expected to Witness a Significant Growth Over the Forecast Period
The rising prevalence of cancer in the Asia-Pacific region is one of the significant factors contributing to the massive demand for remote patient monitoring systems.
According to an article published by the National Library of Medicine, in February 2022, there will be approximately 4,820,000 new cancer cases in China 2022. Additionally, according to an article published by HT Digital Streams Ltd, in May 2022, the number of Indians suffering from cancer is projected to increase to 29.8 million in 2025 from 26.7 million in 2021. The highest incidence last year was in the North (2,408 patients per 100,000) and the Northeast (2,177 per 100,000). It was higher among men. Thus, the increasing burden of cancer among people is expected to raise the need for regular monitoring and lifestyle changes to prevent further health risks, which is expected to increase the demand for health management systems over the forecast period.
Also, the increasing adoption of remote patient monitoring for cancer treatment in this region is expected to drive the growth of the studied segment. For instance, in September 2022 NATCO cancer center, Government General hospital installed Dozee's contactless remote patient monitoring and early warning system in India.
Thus the factors such as the rising prevalence of cancer and adoption of remote patient monitoring systems are expected to contribute to the growth of the studied segment over the forecast period.
Japan is Expected to Show a Significant Growth in the Asia-Pacific Remote Patient Monitoring System Market Over the Forecast Period
The major factors fueling the market growth in the country are the increasing geriatric population and the growing burden of chronic diseases. In addition, the rising focus of the companies to develop advanced remote healthcare monitoring systems to manage diseases and increasing launches are also contributing to the market's growth over the forecast period. For instance, according to the 2022 statistics published by the United Nations Population Fund, in Japan, a large proportion of the living population is aged 15-64 and accounts for 59% in 2022. In addition, as per the same source, 29% of the population will be aged 65 years and above in 2022. Thus, the rising geriatric populations are more prone to develop chronic diseases which require proper monitoring and diagnosis which is expected to increase the adoption of remote patient monitoring to regularly monitor their condition and status, thereby propelling the growth of the studied market.
According to the study published in Springer journal, in February 2022, the estimated nationwide number of patients in Japan with idiopathic pulmonary fibrosis (IPF) was 34,040 with a mean age of 73 years. Most of the population affected by IPF was men with 73%. The prevalence of the diseases was 27 per 100,000 population. The increasing prevalence of IPF further increases the demand for healthcare apps with associated devices (spirometers and pulse oximeters) that are used to monitor breathlessness, medication adherence, symptoms, and the impact of IPF on daily life, thereby boosting market growth. Also, according to the 2022 statistics published by the International Diabetes Federation in the 10th edition of 2021, 11,005,000 people were living with diabetes in 2021 in Japan. In addition, this number is projected to reach 10,542,700 by 2030.
Additionally, the increasing product approvals are expected to drive the growth of the market in Japan. For instance, in May 2022, Japan's Ministry of Health, Labour, and Welfare granted medical device regulatory approval to CureApp for its digital therapeutic app for hypertension that assists patients in maintaining lifestyle improvements as part of their treatment for hypertension and automatically delivers personalized guidance to users, including advice on diet, exercise, and sleep, which are captured via blood pressure monitoring, as well as lifestyle habit logs.
Thus the factors such as the increasing geriatric population and the growing burden of chronic diseases are expected to drive the market's growth in Japan over the forecast period.
Regulatory Landscape
Across Asia-Pacific, remote patient monitoring systems cover both hardware medical devices and software as a medical device (SaMD), which leads to multi-agency oversight and country-specific registration pathways. In Australia, software-based medical devices are regulated by the Therapeutic Goods Administration (TGA) based on intended purpose, typically requiring inclusion in the Australian Register of Therapeutic Goods (ARTG) before supply. In Singapore, the Health Sciences Authority (HSA) uses a defined digital health regulatory framework that shapes how monitoring apps, connected devices, and clinical decision support functions are classified and brought to market.
Recent policy actions have tightened compliance expectations and supported cross-border alignment. South Korea implemented the Digital Medical Products Act on January 24, 2025, bringing digital health products under lifecycle oversight led by the Ministry of Food and Drug Safety (MFDS), which raises post-market monitoring and quality-system expectations for connected RPM offerings. Interoperability requirements also became more concrete in Singapore with the publication of SS 719:2025 and SS 720:2025 on October 31, 2025, creating technical anchors for healthcare terminology and API-based remote clinical monitoring data exchange that affect procurement and integration readiness for multi-parameter monitoring and platform-based RPM deployments.
Competitive Landscape
The Asia-Pacific remote patient monitoring system market is moderate due to the presence of companies operating globally as well as regionally. The competitive landscape includes analysis of companies that hold market shares and are well known, including GE Healthcare, Omron Healthcare, Medtronic PLC, Boston Scientific Corporation, and Abbott Laboratories.
Asia-Pacific Remote Patient Monitoring System Industry Leaders
GE Healthcare
Omron Healthcare
Medtronic PLC
Boston Scientific Corporation
Abbott Laboratories
- *Disclaimer: Major Players sorted in no particular order
Market Opportunities and Future Outlook
Interoperability and home-based care programs are creating practical whitespace for RPM vendors that can connect devices, software, and clinical workflows. Singapore Standards Council published SS 719:2025 and SS 720:2025 (October 2025), establishing common terminology and API standards for remote clinical monitoring, which shifts buying criteria toward solutions that integrate cleanly with provider systems and supports scaled deployments rather than isolated device pilots. Taiwan Ministry of Digital Affairs extended 5G telemedicine platforms to 56 rural townships across 15 counties and cities (May 2025), recording over 60,000 service visits, which highlights demand for monitoring models that operate beyond tertiary hospitals.
Competitive activity in 2026 points to opportunities around AI-enabled cardiac and continuous monitoring, and around hospital-to-home pathways that extend beyond inpatient settings. Omron Healthcare started scaling AI-powered remote ECG diagnosis services in India with Tricog Health (February 2026), indicating a service-led RPM direction that combines connected ECG capture with centralized interpretation. In India, Apollo Hospitals deployed AI-powered continuous patient monitoring using Lifesigns technology across 150 inpatient beds in Madurai (July 2026) and indicated a post-discharge extension, creating a platform entry point for vendors that can support both in-facility surveillance and home healthcare follow-up. Financing and digital engagement also expand the addressable market, with Monitra Health raising capital to scale its upBeat remote cardiac monitoring platform (April 2026) and Ant Group rolling out a nationwide weight management initiative via the AQ AI health app that supports tracking through smart devices (June 2026), reinforcing demand for device connectivity, analytics, and clinically actionable workflows.
Recent Industry Developments
- June 2026: Medtronic announced the launch of the PulseSelect pulsed field ablation (PFA) system in India for atrial fibrillation treatment. The rollout supports higher adoption of advanced cardiac care pathways that often pair procedures with closer rhythm surveillance and monitoring workflows. It also deepens Medtronic's India cardiac footprint adjacent to remote and connected patient monitoring use cases.
- February 2026: Omron Healthcare began scaling AI-powered remote ECG diagnosis services in India with Tricog Health beyond pilot deployments. The effort targets broader clinic and home use, strengthening a service-led model that combines connected ECG capture with AI-assisted interpretation and reporting. It reinforces partnerships as a route to expand RPM capabilities where specialist capacity is constrained.
- November 2025: Omron Healthcare completed a second investment in India-based Tricog Health to advance AI-powered cardiac care and remote monitoring services, including KeeboHealth. The additional capital and alignment support product development and commercialization of connected cardiac monitoring offerings in a large, price-sensitive market. It also positions Omron to pair its hardware portfolio with software and clinical services for recurring revenue streams.
Research Methodology Framework and Report Scope
Market Definition and Coverage
For this study, the market covers systems used to monitor patients outside traditional care settings, where clinical readings are captured by devices and sent to care teams through connected software for follow-up and intervention.
Scope exclusions: We exclude general telehealth visits that do not include ongoing physiological monitoring and data transmission from a device.
Segmentation Overview
- By Type
- Heart Monitors
- Breath Monitors
- Hematology Monitors
- Multi-parameter monitors
- Other Types
- By Application
- Cancer Treatment
- Cardiovascular Disease
- Diabetes Treatment
- Sleep Disorder
- Weight Management and Fitness Monitoring
- Other Applications
- By End-users
- Home Healthcare
- Hospital/Clinics
- Other End Users
- Geography
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Data Sources, Market Sizing, and Validation
Desk Research
Desk research was used to set the factual base for the model and to avoid building assumptions on opinions alone. We relied on public healthcare and digital health references such as WHO country health profiles, OECD health statistics (where available for relevant APAC economies), World Bank population and disease burden indicators, government health ministry portals, and regulator guidance pages for connected medical devices.
Along with these, we reviewed company annual reports, investor presentations, and reputable press coverage to understand product launches, partnerships, and how remote monitoring programs are being deployed across hospitals and home care. Select paid subscriptions for company financials and patent databases were used to cross-check business exposure and innovation activity, especially where public disclosures were limited. These examples are not exhaustive, and other public sources were used for data collection, validation, and research clarification.
Primary Interviews and Surveys
Primary work focused on confirming what is truly counted as remote patient monitoring in APAC and what sits outside the boundary. We spoke with a mix of healthcare providers, home care stakeholders, device and software specialists, and distribution-side contacts across major APAC countries, which helped fill gaps around adoption pace, pricing logic, and usage intensity. Respondent input was also used to sanity-check desk assumptions on which applications are scaling fastest and how monitoring programs are being funded.
Distribution of primary research fieldwork respondents
| Company type | Respondent position | Region |
|---|---|---|
| Top tier: 29% | CXOs: 14% | |
| Mid tier: 53% | Functional/Unit leaders: 42% | |
| Smaller Players: 18% | Managers: 44% |
Market-Sizing & Forecasting
Market sizing was built using top-down and bottom-up methods, with APAC demand reconstructed from country-level healthcare delivery signals and remote monitoring adoption rates. The top-down path starts from the addressable chronic-care and post-acute patient pools and applies penetration by setting of care (home healthcare versus hospital programs), then revenues are derived using typical device and software pricing structures.
To keep totals realistic, we used selective bottom-up checks, including sampled average selling price times estimated active monitoring volumes, and channel checks on how many monitoring units are placed through key care settings. Where public data was thin, gaps were handled through range-based assumptions that were then narrowed using interview feedback. Key inputs used in the model include diagnosed patient volumes for cardiovascular disease and diabetes, pace of home healthcare growth, smartphone and connectivity readiness, monitoring program enrollment levels, and typical replacement or subscription cycles.
For forecasting, we used scenario analysis with an anchor case supported by expert views on reimbursement direction, hospital readmission reduction focus, and national digital health initiatives. Growth rates were then applied at the country and application level and rolled up, with currency conversion kept consistent to reduce timing noise.
Data Validation & Update Cycle
Outputs were checked against independent signals such as chronic disease trends, device adoption indicators, and known program rollouts across large APAC markets, before results were finalized. We also ran variance checks across countries and applications so that outliers are questioned, documented, and corrected when needed.
Before sign-off, the work is reviewed in steps so assumptions, calculations, and conversions are verified, and re-contacts are triggered when an input changes the story materially. Reports are refreshed annually, and interim updates are made when a major regulatory or reimbursement change shifts demand. Before delivery, a final pass is completed so clients receive the latest updated view.
Mordor Intelligence's Asia Pacific Remote Patient Monitoring System Market Market Size Versus Other Published Estimates
It is normal to see different market sizes for the same topic because publishers do not always count the same products, services, and care settings, even when the title looks similar. Differences also come from the base year used, currency timing, and how aggressively adoption is assumed to expand across home care and hospital-led programs.
By tracking APAC device-led monitoring use cases and refreshing reimbursement and enrollment assumptions annually, Mordor Intelligence keeps the count tied to systems where patient readings are captured by monitoring devices and transmitted for clinical follow-up, which filters out broader telehealth-only revenue and wellness-led tracking.
Benchmark comparison
| Source | Market Size | Gaps in Research Methodology |
|---|---|---|
| Mordor Intelligence | USD 1.03 B (2025) | |
| Regional Consultancy A | USD 2.43 B (2024) | Uses a wider boundary labeled as monitoring and care, which can pull in adjacent care services and broader device categories, and it also reports a different base year. |
| Industry Publisher B | USD 1.04 B (2025) | Sits close on the year but can differ on whether software, platforms, and services are bundled into one revenue pool and how long-term price growth is applied through 2034. |
The spread mainly comes from scope choices and how revenue is assigned across devices, software, and care services, followed by base-year and growth-rate differences. When assumptions are grounded in measurable demand pools and checked with real-world adoption signals, the final market total becomes easier to explain and to update over time.
Key Questions Answered in the Report
How big is the Asia-Pacific Remote Patient Monitoring Systems Market?
The Asia-Pacific Remote Patient Monitoring Systems Market size is expected to reach USD 1.23 billion in 2026 and grow at a CAGR of 18.95% to reach USD 2.92 billion by 2031.
What is the current Asia-Pacific Remote Patient Monitoring Systems Market size?
In 2026, the Asia-Pacific Remote Patient Monitoring Systems Market size is expected to reach USD 1.23 billion.
Who are the key players in Asia-Pacific Remote Patient Monitoring Systems Market?
GE Healthcare, Omron Healthcare, Medtronic PLC, Boston Scientific Corporation and Abbott Laboratories are the major companies operating in the Asia-Pacific Remote Patient Monitoring Systems Market.
What years does this Asia-Pacific Remote Patient Monitoring Systems Market cover, and what was the market size in 2025?
In 2025, the Asia-Pacific Remote Patient Monitoring Systems Market size was estimated at USD 1.03 billion. The report covers the Asia-Pacific Remote Patient Monitoring Systems Market historical market size for years: 2020, 2021, 2022, 2023, 2024 and 2025. The report also forecasts the Asia-Pacific Remote Patient Monitoring Systems Market size for years: 2026, 2027, 2028, 2029, 2030 and 2031.
Page last updated on:
